Stockholm 3 Blood Test For Prostate Cancer to Reduce Unnecessary Biopsies

Stockholm3 blood test

From article written December 14, 2026 at news.feinberg.northwestern.edu – Blood Test May Reduce Unnecessary Prostate Cancer Biopsies – according to a recent multi-center trial published in the Journal of Clinical Oncology.   Prostate cancer remains a significant health concern for men, particularly those in high-risk groups. Recent developments in blood testing technology may revolutionize the screening process, potentially reducing …

Read more

TNM Staging System and the Prostate

TNM Staging System for Prostate Cancer

The TNM Staging System plays a crucial role in assessing and managing prostate cancer. This comprehensive approach evaluates the extent of the disease, helping doctors determine the most appropriate treatment options for patients. The TNM system for prostate cancer is based on five key factors: the primary tumor (T), nearby lymph nodes (N), metastasis (M), …

Read more

Prostate Biopsy for Men Explained

Targeted_MRI-US_fusion_prostate_biopsy_at_UCLA

Prostate Biopsy for Men Explained: What to Expect During the Procedure A prostate biopsy is a crucial diagnostic procedure for men concerned about prostate cancer. This test involves removing small tissue samples from the prostate gland to examine them for cancerous cells. A prostate biopsy is currently the only definitive way to diagnose prostate cancer. …

Read more

Prostate Health Index: A Key Tool for Early Cancer Detection

Prostate Health Index, PHI

The Prostate Health Index (PHI) is revolutionizing prostate cancer detection. This innovative blood test combines three biomarkers to provide a more accurate assessment of prostate cancer risk. The PHI test has shown superior performance in identifying clinically significant prostate cancer compared to traditional prostate-specific antigen (PSA) screening alone. PHI addresses a critical need in prostate …

Read more